Recently, Lepu Medical officially released the self-developed "AI-ECG Platform ECG artificial intelligence automatic analysis and diagnosis system". At the release site, Chen Juan, deputy general manager of Lepu Medical, said that AI-ECG Platform is the first industrialization in China. The AI ​​medical technology is also the world's leading AI ECG intelligent analysis and diagnosis technology.
At present, many medical artificial intelligence companies in China are still in the field of product improvement and business model exploration. After receiving the FDA acceptance, Lepu Medical AI-ECG products directly put forward the development ideas of AI medical technology industrialization, and have already done more in advance. The layout of the aspect. To this end, the arterial network interviewed Liu Chang, the person in charge of Lepu Medical AI, to learn more about how Lepu Medical can realize the industrialization of AI medical treatment.
Landing products through hardware vendors' channels
AI medical is a technology, not a product, and its landing is to be carried on other software products or equipment products.
Liu Chang said that as a medical device company that has been cultivating for many years in the medical field, Lepu Medical hopes to build a full ecological ECG industry with various ECG hardware acquisition equipment, automated analysis software platform and expert services by taking AI-ECG technology as the core. Chain, leading the technological revolution in the field of electrocardiogram, allowing ECG AI analysis and diagnosis technology and services to enter the hospital, enter the grassroots, enter the family, and meet the growing demand for many ECG inspections at home and abroad.
At present, Lepu Medical firstly upgrades its static and dynamic ECG products by using AI-ECG auxiliary diagnostic system to improve their competitiveness in the industry.
Static ECG cut from the department
In terms of static ECG, Shenzhen Kewell Electronics Co., Ltd., a wholly-owned subsidiary of Lepu Medical, is a well-known research and development enterprise of electrocardiograph equipment in China. So far, Cleveland has obtained a number of ECG products from China CFDA and EU. CE and FDA certificates, a variety of static ECG and multi-parameter monitors developed by Cavour have been sold in domestic and foreign markets.
The AI-ECG Platform can be deployed in the hospital department. A set of ECG analysis and diagnosis network system containing AI-ECG auxiliary diagnosis system is established in the hospital. The static electrocardiogram equipment of Cavour can be directly used in this system to facilitate the hospital. It is a simple and rapid deployment of artificial intelligence ECG analysis and diagnosis system in grassroots hospitals.
This means that if you use Cleveland's static ECG device, you can automate the entire process from ECG, data upload, AI analysis, to report generation; after the doctor has confirmed it, you can print the report. As an ECG-assisted diagnostic system, the AI-ECG Platform allows doctors to modify the AI ​​analysis diagnostic results and then regenerate the report based on the doctor's modifications.
Liu Chang also stressed that in order to solve the lack of professional doctors in some primary medical institutions, AI-ECG can provide remote diagnosis and treatment of remote static ECG artificial intelligence. When using the Kelver static ECG equipment, the primary hospital directly transmits the ECG data to the ECG room of the central hospital through a secure network connection, and conducts preliminary diagnostic analysis by the AI-ECG Platform in the ECG room for review by the central hospital doctor. . The central hospital doctor finally sends the confirmed report to the primary hospital through the network to the patient.
Patients are paid according to the normal static ECG examination fee and no additional fees are required. For the hospital, ECG equipment and software are still purchased as usual, but the software includes the clinically validated AI-ECG auxiliary diagnostic system. In this way, the diagnosis and treatment time of the doctors in the central hospital can be greatly saved, and the AI-ECG comprehensively improves the accuracy of the electrocardiogram analysis, which can help the doctor to make an accurate diagnosis.
The combination of AI-ECG and Cairwell's hardware products is to create an intelligent ECG automatic analysis and diagnosis system for hospital departments, and AI-ECG technology has also enhanced the core competitiveness of Cairwell. Wall has further developed a smart ECG inspection terminal equipment and laid a good foundation.
Dynamic ECG equipment focuses on remote cloud services
In terms of dynamic ECG, Lepu subsidiary Eucalyptus has been engaged in the research of dynamic ECG since 2003. At present, the market share in the field of dynamic ECG is the first, covering nearly 1,000 hospitals. These hospitals contain some large-scale top three. Hospitals and many primary hospitals.
The profit of Dynamic ECG is mainly derived from services. The patient wears the dynamic electrocardiographic equipment (Xi'anbao) of Eucalyptus, and the hospital charges the corresponding fees according to the national medical insurance regulations. The specific cost and service type (whether there is real-time warning, wearing time, etc.) are related.
The hospital uploads the patient's data on the machine to the cloud server of Eucalyptus, and then conducts preliminary analysis and diagnosis through the AI-ECG platform system. Then the team of eucalyptus doctors conducts follow-up audits, and finally sends the diagnosis report to the hospital and hospital. The professional doctor reviews the report and sends it to the patient. The hospital is similar to outsourcing this business to Eucalyptus.
The AI-ECG Platform began trial operation in Eucalyptus in August 2017. Over the past six months, ubiquitous ECG data have been analyzed for tens of thousands of patients. The performance and accuracy of the analysis have been fully affirmed, especially in the diagnosis of arrhythmia events such as supraventricular and premature ventricular contractions, atrial fibrillation, ventricular tachycardia, conduction block and pre-excitation syndrome. It has obvious advantages and is deeply loved by the team of Eucalyptus doctors, which has greatly enhanced the competitive advantage of Eucalyptus Dynamic ECG Analysis Service.
AI-ECG also helps Optima's real-time early warning service to provide accurate and timely analysis. The professional doctor team on the 7x24 eucalyptus team always pays attention to the real-time warning data sent by Xinanbao through the mobile communication network. Based on the AI-ECG analysis, Conduct accurate and professional analysis and judgment and necessary operational measures to escort the lives of some critically ill patients.
For patients, there is currently no additional fee for AI-ECG, which is still paid according to national fees; for Eucalyptus, AI-ECG has increased its core competitiveness.
Liu Chang said that Lepu basically covers the hospital application scenarios of dynamic ECG and static ECG, and has a complete industrial chain of software and hardware R&D, production and doctor team. As long as the CFDA, FDA and CE registration certificates are approved, these application models can be immediately implemented in the domestic and international markets. At present, the FDA has accepted their application, and it is expected to obtain evidence in the second half of the year. At the same time, CFDA and CE registration work is underway, and information can be submitted soon.
Regarding the issue of CFDA certification, Liu Chang said that the current stage is rapidly advancing. In essence, AI-ECG only updates the traditional analysis algorithm, using advanced artificial intelligence algorithms to improve the sensitivity and positive predictive rate of arrhythmia event detection to the level of professional ECG doctors, but this system is still positioned. The role of assisted diagnosis.
Application of primary health care institutions such as social health
The second application scenario of Lepu Medical AI ECG is to serve a large number of grassroots hospitals, individual clinics, medical centers, and old-age care institutions that lack professional electrocardiographers.
Doctors who can read ECG at the grassroots level are scarce. If the ECG equipment and AI-ECG analysis and diagnosis platform are directly and simply provided to the general hospitals, the doctors may not be able to review the reports issued by the AI, and they will not be able to sign the report. confirm. Therefore, one of Lepu’s ideas is to conduct centralized training for customers (primary doctors) when they push products at the grassroots level, to guide them to master basic ECG reading and analysis skills, to understand the ability of AI-ECG analysis and diagnosis, and to empower with new technologies. At the same time as the grassroots level, the skills of the grassroots doctors are provided through training.
In this way, AI-ECG technology can be truly promoted at the grassroots level to ensure that the primary doctors have the ability to issue AI-ECG ECG examination reports. Of course, the primary hospital can also adopt the AI-ECG grading diagnosis and treatment mode; for the dynamic electrocardiogram, the eucalyptus remote dynamic electrocardiogram service mode can be used, which can be appropriately selected according to the specific conditions of each primary hospital. However, no matter what the situation is, Lepu AI-ECG technology, products and services can meet the needs of users, and solve the problem that some grassroots hospitals cannot carry out ECG examination for patients with cardiovascular diseases.
Entering the field of health consumption
In addition to applying AI-ECG technology to medical institutions, Lepu intends to enter the health consumer sector, which is a broader market. Lepu Medical can raise the level of ECG analysis and diagnosis of wearable devices to the level of professional doctors, so that wearable devices (heart patches, watches, bracelets, etc.) truly provide medical level data and monitor the patient's ECG. Make wearable devices more widely used.
Liu Chang said that most of the current wearable devices related to ECG belong to single-lead dynamic electrocardiogram examination equipment. Generally, the patient's electrocardiogram can be continuously detected for 1 to 7 days. During the detection process, the patient's test data is transmitted to the user's mobile phone in real time. Perform simple calculations and analysis, give some basic heart rate measurement calculations, and some products can provide more complicated arrhythmia analysis, but due to the technical limitations of traditional ECG analysis algorithms, the reliability of these analysis is relatively low, for users. Help is of little significance and may even be misleading.
Liu Chang said that a number of wearable electronic products owned by Lepu Medical have obtained or are applying for certifications such as FDA, CFDA, CE, etc., and gradually promoted to the domestic and overseas markets. Lepu Concentric Steward Lite is the first wearable Holter consumer medical product with FDA-approved AI-ECG technology and cFDA and FDA approval. The Checkme Lite real-time detection data is sent to the Lepu Concentric Manager via Bluetooth via Bluetooth (Concentric Manager is an application software for postoperative rehabilitation management of stents), aiming to establish a post-surgical rehabilitation service platform.
This platform can provide users with all kinds of high-quality services, including one-stop doctor consultation, medical lectures, health mall, post-operative daily rehabilitation program and rehabilitation encyclopedia knowledge, so that users can get professional guidance after stenting), concentric butler The APP then uploads the real-time detection data to the AI-ECG Platform deployed in the cloud for ECG real-time early warning analysis, and sends the analysis and generated warning results to the doctor analysis team on the eucalyptus 7x24 watch. If the audit confirms the intervention, the doctor team The emergency contact or the patient's doctor reserved by the patient will be contacted, and the warning result will be pushed to the user's mobile phone.
This real-time alert service is a high value-added fee-based service that helps patients with severe arrhythmia to detect crisis events in a timely manner. Chen Juan, deputy general manager of Lepu, introduced the recent cases. Eucalyptus' AI-ECG early warning system made early warnings and obtained valuable rescue time for patients.
At the same time, Concentric Butler also provides another comprehensive analysis and diagnosis service, which uploads the collected multi-day long-range data to the AI-ECG Platform cloud of Eucalyptus for analysis and diagnosis, and then passes the review and confirmation by the doctor team to send the report to the concentric butler. . Of course, concentric butler users can request automated analysis and diagnosis of simple AI-ECG without the confirmation of the team of Eucalyptus doctors.
This mode is currently free, but the AI-ECG diagnosis only provides a simple or abnormal analysis. If you have an abnormality and want to seek medical attention, Lepu will provide additional medical services, which is an additional fee-based service. In this way, we can meet the needs of all levels of consumers in many aspects.
Expand new areas
In addition to traditional ECG analysis and diagnosis, AI-ECG technology can also be applied to multi-parameter monitors to provide comprehensive and accurate comprehensive analysis and early warning of multi-modal physiological parameters. The core of this warning is ECG analysis. The Lepu AI team is working with domestic universities and research institutes to develop artificial intelligence-assisted diagnostic technology based on physiological signals (EC, EEG, pulse wave, etc.) and its new service model. It is hoped that AI-ECG will be further developed. The technology is applied to a wider range of physiological signal monitoring analysis. The Lepu Medical AI technical team is working with the top AI chip manufacturers in China to develop a new generation of AI ECG equipment.
Liu Chang told the arterial network that Lepu Medical is to establish a whole industrial chain ecosystem centered on AI-ECG technology and around the cardiovascular field. This ecosystem includes AI-ECG platform software systems, medical-grade static (Caiwall) and Holter (Ugly) hardware products, network analysis service platform (Ugari), physician analysis client, wearable devices, Multi-parameter monitoring and concentric butlers can provide real-time and accurate medical-grade cardiovascular disease prevention screening and monitoring services for family rehabilitation personnel and potential patients with heart disease.
After more than half a year of clinical trials, the level of the AI-ECG ECG-assisted diagnostic system of Lepu Medical has reached the level of professional doctors, and reached the level of experts in some difficult diagnosis. AI-ECG technology will provide a simple and effective ECG examination method for patients with cardiovascular disease, so that patients can enjoy the AI-ECG analysis and services provided by Lepu Medical at any time and anywhere.
Porcini Mushrooms,Frozen Porcini,Fresh Porcini,Boletus Porcini
Guangyun Agricultural Biotechnology (Jiangsu) Co., Ltd , https://www.7-mushrooms.com